Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.8B | 8.6B | 7.3B | 6.0B |
| Cost of revenue | 5.4B | 7.1B | 5.8B | 4.8B |
| Gross profit | 1.4B | 1.6B | 1.5B | 1.3B |
| Operating expense | ||||
| Research & development | 655.4M | 604.5M | 605.1M | 523.2M |
| Selling general and admin | 217.9M | -264.4M | 433.9M | -29.8M |
| Other operating expenses | 21.6M | 25.8M | 23.1M | 20.4M |
| Operating income | 617.2M | 886.2M | 762.6M | 665.7M |
| Non operating interest income | ||||
| Income | 2.7M | 2.9M | 2.8M | 3.1M |
| Expense | 6.5M | 4.6M | 24.1M | -6.3M |
| Other income expense | — | — | — | — |
| Pretax income | 668.7M | 628.8M | 536.4M | 481.7M |
| Tax provision | 82.0M | 28.1M | -34.8M | 25.6M |
| Net income | 586.7M | 600.8M | 571.3M | 456.2M |
| Basic EPS | 1.1 | — | — | — |
| Diluted EPS | 1.1 | — | — | — |
| Basic average shares | 554.5M | — | — | — |
| Diluted average shares | 554.5M | — | — | — |
| EBITDA | 673.4M | 919.1M | 784.9M | 520.1M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -4.5M | -2.7M | -2.9M | -2.5M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |